On a quarter-on-quarter basis, the company’s net profit slipped 30.90% against ₹4,649 Crore in the previous quarter.
As part of this offer, there is an offer for sale of up to 11.05 million Equity Shares.
This is the first such announcement by the company in over a period of nine years that the company will be issuing bonus shares.
Praj informed the bourses that it has also established a Centre of Excellence (CoE) and Innovation for Biopolymers in collaboration with ICT Mumbai.
Tejas Networks stock has witnessed a total of 38% dip in the last one year, and 11% dip in the last one month.
USFDA's final approval is available for Zydus Lifesciences and group companies, and this will allow the group to sell the product in the highly regulated US market.
Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US
The solar projects are located across several states in India, enhancing Inox Green's pan-India renewable energy footprint.
Net profit increased 34% YoY to ₹726.2 crore, bolstered by robust volume expansion and operating efficiency.
Out of the total April 2025 sales, 24,833 units were sold locally and 2,491 units exported, a balanced input from the domestic and overseas market.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.